Vendor, Durham, NC
Health Decisions, Inc.
UEI CMKQYLSLNJG1, CAGE 3FAM0
10 awards and $4,934,221 obligated between March 14, 2025 and September 10, 2026, 90% under full and open competition, against 2.0 offers on average where reported. 2 of the awards trace back to a SAM.gov solicitation on this site.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $4,934,221 |
| Professional, Scientific, and Technical ServicesNAICS 541712 | $0 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 9 |
| Full and Open Competition | 1 |
| Small Business Set Aside - Total | 1 |
| Delivery Order | 9 |
Solicitations it won
SAM.gov opportunities whose award USAspending attributes to this vendor.
- NICHD Contraceptive Clinical Trials Network Statistical and Clinical Coordinating Center
National Institutes of Health, National Institutes of Health Nichd
JustificationNAICS 541715North Carolina75N94019D00004Awarded to Health Decisions, Inc.
Posted Jan 8, 20252 publications
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N94025F00002Delivery Order, July 25, 2025, Full and Open Competition After Exclusion of Sources | National Institutes of Health NichdNational Institutes of Health | Nichd: R&d: Supporting the Phase Iib Clinical Trial of Subcutaneous Levonorgestrel Butanoate (Lb) for Female Contraception: Non-SeverableNAICS 541715, PSC AN12 | $1,286,724 |
| 75N94025F00001Delivery Order, April 30, 2025, Full and Open Competition After Exclusion of Sources | National Institutes of Health NichdNational Institutes of Health | Nichd: R&d: Coordination, Monitoring, Follow-Up, Evaluation, and Completion of a Clinical Trial of Nestorone Testosterone Gel for Male ContrNAICS 541715, PSC AN12 | $1,230,826 |
| 75N94023F00002Delivery Order, April 10, 2025, Full and Open Competition After Exclusion of Sources | National Institutes of Health NichdNational Institutes of Health | Nichd: R&d: Statistical and Clinical Coordinating Services for Groups C and D of CCN021 Entitled, "a Study to Evaluate the PK and PD of Im oNAICS 541715, PSC AN12 | $901,922 |
| 75N94019F00126Delivery Order, May 21, 2025, Full and Open Competition After Exclusion of Sources | National Institutes of Health NichdNational Institutes of Health | Nichd: R&d: Status Determination and Prioritization of Pipeline Products Undergoing Clinical Trials for Male and Female Contraception: Non-SNAICS 541715, PSC AN12 | $898,234 |
| 75N94019F00125Delivery Order, May 21, 2025, Full and Open Competition After Exclusion of Sources | National Institutes of Health NichdNational Institutes of Health | Nichd: R&d: Coordination of Clinical Trials of Nestorone Testosterone Gel for Male Contraception: SeverableNAICS 541715, PSC AN12 | $519,967 |
| 75N94023F00001Delivery Order, April 21, 2025, Full and Open Competition After Exclusion of Sources | National Institutes of Health NichdNational Institutes of Health | Coordination, Monitoring, Follow-Up, and Evaluation of a Clinical Trial of Nestorone Testosterone Gel for Male ContraceptionNAICS 541715, PSC AN12 | $69,988 |
| 75N94023F00003Delivery Order, March 14, 2025, Full and Open Competition After Exclusion of Sources | National Institutes of Health NichdNational Institutes of Health | Nichd: R&d: Finalization, Procurement of Regulatory Approval, and Complete Start-Up Activities for the Ovaprene Vaginal Device Clinical TriaNAICS 541715, PSC AN12 | $26,559 |
| 75N94024F00002Delivery Order, July 14, 2025, Full and Open Competition After Exclusion of Sources | National Institutes of Health NichdNational Institutes of Health | Acquisition of the Nestorone Estradiol (Nes/E2) Vaginal RingNAICS 541715, PSC AN12 | $0 |
| HHSN27500005Delivery Order, September 26, 2025, Full and Open Competition | National Institutes of Health NichdNational Institutes of Health | Evaluation of the Pharmacokinetic Profile, Effects on the Mechanisms of Contraceptive Efficacy and Safety of Multipurpose Prevention TechnolNAICS 541712, PSC AN12 | $0 |
| 75N94019D00004April 1, 2026, Full and Open Competition After Exclusion of Sources, 2 offersSolicitation | National Institutes of Health NichdNational Institutes of Health | Nichd: R&d: the Statistical and Clinical Coordinating Center IDIQNAICS 541715, PSC AN12 | $0 |
- Places of performance
- North Carolina
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 25 across 10 awards